Dose-dependent response seen with increasing number of cardiometabolic diseases and cognitive decline
Among individuals with type 2 diabetes, country-standardized cognitive score may predict risk for cardiovascular events
Association stronger in most recent decades and among those with schizophrenia
Clinical outcomes and cost-effectiveness of simulated treatment strategies for injection drug use-linked IE compared in modeling study
10- and 30-year CV risk significantly higher in patients with bipolar disorder, schizophrenia, schizoaffective disorder
Reduction seen in rate of change in modifiable cardiovascular risk, but most changes in individual modifiable risk factors were not significant
And, one in four COVID-19 survivors says the virus impacted their heart health
Findings independent of each other, with an even stronger effect seen for women with high levels of social isolation and loneliness
Risks for premature mortality, suicide among individuals with common noncommunicable diseases may be increased by psychiatric comorbidity
Higher neuroticism and worry levels in men associated with cardiometabolic risk across time